Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis
Top Cited Papers
- 1 June 2015
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 100 (6), 2171-2180
- https://doi.org/10.1210/jc.2015-1218
Abstract
Objective: We aimed to estimate pooled percentages of patients with adrenal insufficiency after treatment with corticosteroids for various conditions in a meta-analysis. Secondly, we aimed to stratify the results by route of administration, disease, treatment dose, and duration. Methods: We searched seven electronic databases (PubMed, MEDLINE, EMBASE, COCHRANE, CENTRAL, Web of Science, and CINAHL/Academic Search Premier) in February 2014 to identify potentially relevant studies. Original articles testing adult corticosteroid users for adrenal insufficiency were eligible. Results: We included 74 articles with a total of 3753 participants. Stratified by administration form, percentages of patients with adrenal insufficiency ranged from 4.2% for nasal administration (95% confidence interval [CI], 0.5–28.9) to 52.2% for intra-articular administration (95% CI, 40.5–63.6). Stratified by disease, percentages ranged from 6.8% for asthma with inhalation corticosteroids only (95% CI, 3.8–12.0) to 60.0% for hematological malignancies (95% CI, 38.0–78.6). The risk also varied according to dose from 2.4% (95% CI, 0.6–9.3) (low dose) to 21.5% (95% CI, 12.0–35.5) (high dose), and according to treatment duration from 1.4% (95% CI, 0.3–7.4) (1 year) in asthma patients. Conclusions: 1) Adrenal insufficiency after discontinuation of glucocorticoid occurs frequently; 2) there is no administration form, dosing, treatment duration, or underlying disease for which adrenal insufficiency can be excluded with certainty, although higher dose and longer use give the highest risk; 3) the threshold to test corticosteroid users for adrenal insufficiency should be low in clinical practice, especially for those patients with nonspecific symptoms after cessation.Keywords
This publication has 79 references indexed in Scilit:
- Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort StudyPLOS ONE, 2013
- Adrenal insufficiencyThe Lancet, 2003
- Use of oral corticosteroids in the United KingdomQJM: An International Journal of Medicine, 2000
- Glucocorticoid-Induced Adrenal InsufficiencyJAMA, 1999
- Hypothalamic-Pituitary-Adrenal Axis Suppression and Inhaled Corticosteroid TherapyNeuroimmunomodulation, 1998
- Adrenal InsufficiencyNew England Journal of Medicine, 1996
- Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisoneAmerican Journal Of Medicine, 1993
- The Effect of Long-Term Glucocorticoid Therapy on Pituitary–Adrenal Responses to Exogenous Corticotropin-Releasing HormoneNew England Journal of Medicine, 1992
- HPA Failure and Glucocorticoid TherapyHospital Practice, 1984
- ADRENAL SUPPRESSION AFTER SHORT-TERM CORTICOSTEROID THERAPYThe Lancet, 1979